Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 3, No. 3, 2011
Issue release date: April 2011
Section title: Review
Free Access
J Innate Immun 2011;3:274–279

Natural Killer Cell Responses to Viral Infection

Brandstadter J.D.a · Yang Y.a, b
aMolecular Cancer Biology Program and bDepartment of Medicine, Duke University Medical Center, Durham, N.C., USA
email Corresponding Author

Dr. Yiping Yang

Department of Medicine

Duke University Medical Center

Box 103005, Durham, NC 27710 (USA)

Tel. +1 919 668 0932, E-Mail yang0029@mc.duke.edu


  1. Cerwenka A, Lanier LL: Natural killer cells, viruses and cancer. Nat Rev Immunol 2001;1:41–49.
  2. Kiessling R, Klein E, Wigzell H: ‘Natural’ killer cells in the mouse. 1. Cytotoxic cells with specificity for mouse moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975;5:112–117.
  3. Herberman RB, Nunn ME, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. 1. Distribution of reactivity and specificity. Int J Cancer 1975;16:216–229.
  4. Karre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986;319:675–678.
  5. Orange JS: Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 2002;4:1545–1558.
  6. Biron CA, Byron KS, Sullivan JL: Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989;320:1731–1735.
  7. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM: Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983;131:1531–1538.
  8. Lee SH, Miyagi T, Biron CA: Keeping NK cells in highly regulated antiviral warfare. Trends Immunol 2007;28:252–259.
  9. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagne F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E: Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 2005;102:13224–13229.
  10. Khakoo SI, Carrington M: KIR and disease: a model system or system of models? Immunol Rev 2006;214:186–201.
  11. Lanier LL: Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008;9:495–502.
  12. Bryceson YT, Ljunggren HG, Long EO: Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009;114:2657–2666.
  13. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, Blattenberger EA, Dubbelde CE, Stone LR, Scalzo AA, Yokoyama WM: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001;292:934–937.
  14. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT, Scalzo AA, Fremont DH, Yokoyama WM: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002;99:8826–8831.
  15. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL: Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002;296:1323–1326.
  16. French AR, Yokoyama WM: Natural killer cells and viral infections. Curr Opin Immunol 2003;15:45–51.
  17. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A: Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001;409:1055–1060.
  18. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, Zakay-Rones Z, Porgador A, Mandelboim O: Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006;7:517–523.
  19. Magri G, Muntasell A, Romo N, Saez-Borderias A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, Lopez-Botet M: NKp46 and DNAM-1 NK cell receptors drive the response to human cytomegalovirus infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2011;117:848–856. DOI: blood-2010-08-301374.
  20. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH: The role of the NKg2d immunoreceptor in immune cell activation and natural killing. Immunity 2002;17:19–29.
  21. Guma M, Angulo A, Lopez-Botet M: NK cell receptors involved in the response to human cytomegalovirus infection. Curr Top Microbiol Immunol 2006;298:207–223.
  22. Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C, Delale T, Stacey KJ, Trinchieri G, Degli-Esposti MA: Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005;6:1011–1019.
  23. Martinez J, Huang X, Yang Y: Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog 2010;6:e1000811.
  24. Zhu J, Huang X, Yang Y: NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus. J Immunol 2010;185:7480–7486.
  25. Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL: Viral evasion of natural killer cells. Nat Immunol 2002;3:1006–1012.
  26. Eissmann P, Evans JH, Mehrabi M, Rose EL, Nedvetzki S, Davis DM: Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol 2010;184:6901–6909.
  27. Giurisato E, Cella M, Takai T, Kurosaki T, Feng Y, Longmore GD, Colonna M, Shaw AS: Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse. Mol Cell Biol 2007;27:8583–8599.
  28. Bryceson YT, March ME, Ljunggren HG, Long EO: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006;107:159–166.
  29. Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M: NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol 2002;3:1150–1155.
  30. Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH: Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 2002;3:1142–1149.
  31. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L, Moretta A: CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004;101:10116–10121.
  32. Schmidt KN, Leung B, Kwong M, Zarember KA, Satyal S, Navas TA, Wang F, Godowski PJ: APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 2004;172:138–143.
  33. Hart OM, Athie-Morales V, O’Connor GM, Gardiner CM: TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol 2005;175:1636–1642.
  34. Pesce I, Monaci E, Muzzi A, Tritto E, Tavarini S, Nuti S, De Gregorio E, Wack A: Intranasal administration of CpG induces a rapid and transient cytokine response followed by dendritic and natural killer cell activation and recruitment in the mouse lung. J Innate Immun 2010;2:144–159.
  35. Mian MF, Lauzon NM, Andrews DW, Lichty BD, Ashkar AA: FimH can directly activate human and murine natural killer cells via TLR4. Mol Ther 2010;18:1379–1388.
  36. Long EO: Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev 2008;224:70–84.
  37. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A: Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol 1994;55:341–380.
  38. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO: Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995;3:801–809.
  39. Karlhofer FM, Ribaudo RK, Yokoyama WM: MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992;358:66–70.
  40. Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO: Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 2003;23:6291–6299.
  41. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH: A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005;105:4416–4423.
  42. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005;436:709–713.
  43. Orr MT, Murphy WJ, Lanier LL: ‘Unlicensed’ natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 2010;11:321–327.
  44. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM: Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2001;2:951–956.
  45. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA: Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002;169:4279–4287.
  46. Garcia-Sastre A, Biron CA: Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006;312:879–882.
  47. Orange JS, Biron CA: An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996;156:1138–1142.
  48. Gherardi MM, Ramirez JC, Esteban M: IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system. J Gen Virol 2003;84:1961–1972.
  49. Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA: Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 2000;1:70–76.
  50. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T: The trafficking of natural killer cells. Immunol Rev 2007;220:169–182.
  51. Walzer T, Chiossone L, Chaix J, Calver A, Carozzo C, Garrigue-Antar L, Jacques Y, Baratin M, Tomasello E, Vivier E: Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007;8:1337–1344.
  52. Natuk RJ, Welsh RM: Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J Immunol 1987;138:877–883.
  53. Salazar-Mather TP, Orange JS, Biron CA: Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 1998;187:1–14.
  54. Hokeness KL, Kuziel WA, Biron CA, Salazar-Mather TP: Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J Immunol 2005;174:1549–1556.
  55. Thapa M, Kuziel WA, Carr DJ: Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 2007;81:3704–3713.
  56. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, Lu MY, Wu-Hsieh BA, Lin YL, Lane TE, Luster AD, Liao F: Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol 2006;177:3185–3192.
  57. Saudemont A, Garcon F, Yadi H, Roche-Molina M, Kim N, Segonds-Pichon A, Martin-Fontecha A, Okkenhaug K, Colucci F: p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proc Natl Acad Sci USA 2009;106:5795–5800.
  58. Prlic M, Gibbs J, Jameson SC: Characteristics of NK cell migration early after vaccinia infection. J Immunol 2005;175:2152–2157.
  59. Lee SH, Biron CA: Here today – not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections. Eur J Immunol 2010;40:923–932.
  60. Novelli F, Casanova JL: The role of IL-12, IL-23 and IFN-gamma in immunity to viruses. Cytokine Growth Factor Rev 2004;15:367–377.
  61. Tay CH, Welsh RM: Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 1997;71:267–275.
  62. Colucci F, Caligiuri MA, Di Santo JP: What does it take to make a natural killer? Nat Rev Immunol 2003;3:413–425.